ARCHIVES

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

This article is from The Cancer Letter archive.

Vol. 13 No. 16 | April 17, 1987

Download PDF Visit The Full Archive

Related Articles

Asks BSC For Advice On Centers Funding, Other Pressing Issues, But Doesn’t Get Any

March 30, 1990

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003

President Obama Signs Spending Bill Giving NCI 2.8 Percent Increase

December 18, 2009

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

Weight Gain After Diagnosis Increases Risk Of Death

December 28, 2007